Sunday Program

Simultaneous Sessions | Science in progress | Clinical Trial Update | Hematology-in-focus Session | Plenary Session 2 |

HEMATOLOGY-IN-FOCUS SESSION
09:30 – 10:15, Hall A2

PI3K SIGNALING IN ACUTE MYELOID LEUKEMIA
Chair: M. Alberich Jorda (Harvard Medical School, Boston, USA)

PI3K SIGNALING LESSONS FROM KNOCK OUT STUDIES
B Vanhaesebroeck (Institute of Cancer, London, United Kingdom)

PI3K AND MTOR SIGNALING IN ACUTE MYELOID LEUKEMIA
D Bouscary (INSERM, Paris, France)

---

HEMATOLOGY-IN-FOCUS SESSION
09:30 – 10:15, Auditorium 1

TRANSFORMED FOLLICULAR LYMPHOMA
Chair: U Jäger (Medical University of Vienna, Vienna, Austria)

MOLECULAR AND CYTOGENETIC EVENTS ASSOCIATED WITH TRANSFORMATION
F Jardin (University Hospital Ambroise Paré, Rouen, France)

THERAPEUTIC OPTIONS IN TRANSFORMED FOLLICULAR LYMPHOMA
S Montoto (St. Bartholomew's Hospital, London, United Kingdom)

---

HEMATOLOGY-IN-FOCUS SESSION
09:30 – 10:15, Hall A3

MOLECULAR PATHOGENESIS OF T-ACUTE LYMPHOBLASTIC
LEUKEMIA
Chair: I Roberts (Imperial College, London, United Kingdom)

ROLE OF MYB ONCOGENE IN T-ACUTE LYMPHOBLASTIC LEUKEMIA
J Cools (University of Leuven, Leuven, Belgium)

NEW GENETIC ABNORMALITIES IN T-ACUTE LYMPHOBLASTIC LEUKEMIA BY ARRAY-CGH
J Meijerink (Erasmus Medical Center, Rotterdam, The Netherlands)

---

HEMATOLOGY-IN-FOCUS SESSION
09:30 – 10:15, Auditorium 2

NEW DEVELOPMENTS IN MANAGING PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA
Chair: F Lo Coco (University Tor Vergata, Rome, Italy)

MOLECULAR MONITORING OF ACUTE PROMYELOCYTIC LEUKEMIA
D Grimwade (King's College London School of Medicine, London,
United Kingdom)

THE ROLE OF NEW AGENTS IN ACUTE PROMYELOCYTIC LEUKEMIA
M Sanz (University Hospital La Fe, Valencia, Spain)

---

HEMATOLOGY-IN-FOCUS SESSION
09:30 – 10:15, Hall C1

THROMBOTIC MICROANGIOPATHY
Chair: P Coppo (Hôpital Saint-Antoine, Paris, France)

CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME
P Meroni (University of Milan, Milan, Italy)

ADAMTS13, VON WILLEBRAND FACTOR AND THROMBOTIC THROMBOCYTOPENIC PURPURA
D Lane (Imperial College London, London, United Kingdom)

---

HEMATOLOGY-IN-FOCUS SESSION
09:30 – 10:15, Hall C2

PRESERVATION OF FERTILITY IN YOUNG PATIENTS AFTER TREATMENT OF HEMATOLOGICAL MALIGNANCIES
Chair: M van der Kaaij (University Medical Centre Groningen, Groningen,
The Netherlands)

ISSUES OF FERTILITY PRESERVATION IN WOMEN TREATED FOR HEMATOLOGICAL MALIGNANCIES
Z Blumenfeld (Rambam Medical Center, Haifa, Israel)

ASSISTED REPRODUCTIVE TECHNOLOGY OF RELEVANCE FOR LYMPHOMA / LEUKEMIA SURVIVORS
M Rosendahl (Copenhagen University Hospital, Copenhagen, Denmark)

---

HEMATOLOGY-IN-FOCUS SESSION
09:30 – 10:15, Hall C3

HEMOJUVELIN AND BONE MORPHOGENETIC PROTEINS,
THE KEY TO HEPCIDIN REGULATION
Chair: C Beaumont (INSERM, Paris, France)

THE BONE MORPHOGENETIC PROTEINS CO-RECEPTOR HEMOJUVELIN REGULATES IRON METABOLISM
H Lin (Harvard Medical School, Boston, USA)

ORIGIN AND FUNCTION OF SOLUBLE HEMOJUVELIN
C Camaschella (University Vita-Salute San Raffaele, Milan, Italy)

---

HEMATOLOGY-IN-FOCUS SESSION
09:30 – 10:15, Hall C4

BONE MARROW FAILURE
Chair: C Niemeyer (University Children's Hospital, Freiburg, Germany)
FANCONI ANEMIA PROTEINS AND THE DNA DAMAGE RESPONSE NETWORK
J de Winter (VU Medical Center, Amsterdam, The Netherlands)
DIAMOND-BLACKFAN ANEMIA DEFECTS IN RIBOSOME FUNCTION AS A CAUSE OF BONE MARROW FAILURE
S Karlsson (Lund University, Lund, Sweden)